Dadi Education Holdings Limited (HKG:8417)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	21	21	25	28	47	53
Market Cap Growth	-14.29%	-14.29%	-12.50%	-40.74%	-10.00%	15.38%
Enterprise Value	-17	-22	-19	-24	-12	-6
Last Close Price	0.01	0.01	0.01	0.02	0.03	0.03
PE Ratio	-	-	-	-	-	8.69
PS Ratio	1.26	1.26	1.30	1.54	2.54	3.05
PB Ratio	0.44	0.44	0.44	0.45	0.65	0.67
P/TBV Ratio	0.44	0.44	0.44	0.45	0.65	0.68
P/FCF Ratio	-	-	-	-	-	7.10
P/OCF Ratio	-	-	-	-	-	7.03
EV/FCF Ratio	2.79	-	-	-	-	-
Debt / Equity Ratio	0.05	0.05	0.06	0.08	0.04	0.05
Debt / EBITDA Ratio	0.61	0.61	0.66	0.96	0.41	-
Debt / FCF Ratio	-	-	-	-	-	0.52
Asset Turnover	0.28	0.28	0.28	0.24	0.23	0.21
Quick Ratio	7.85	7.85	8.88	11.46	13.57	15.33
Current Ratio	8.00	8.00	9.10	11.73	13.85	15.58
Return on Equity (ROE)	-14.60%	-14.60%	-9.88%	-13.27%	-6.04%	9.38%
Return on Assets (ROA)	2.47%	2.47%	3.28%	2.70%	3.19%	-1.76%
Return on Capital (ROIC)	2.66%	2.66%	3.48%	2.82%	3.30%	-1.83%
Return on Capital Employed (ROCE)	4.80%	4.80%	6.10%	4.90%	5.70%	-
Earnings Yield	-39.74%	-39.74%	-25.89%	-35.21%	-10.89%	11.50%
FCF Yield	-28.66%	-28.66%	-27.71%	-22.91%	-4.22%	14.08%

Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.